IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma
This study is ongoing, but not recruiting participants.
Sponsor:
immatics Biotechnologies GmbH
Information provided by (Responsible Party):
immatics Biotechnologies GmbH
ClinicalTrials.gov Identifier:
NCT01265901
First received: December 22, 2010
Last updated: February 8, 2013
Last verified: May 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | April 2014 |
| Estimated Primary Completion Date: | April 2014 (Final data collection date for primary outcome measure) |